![]() The vaccine demonstrated a strong immune response, and the most common side effects were mild, and self-resolved within a few days of vaccination. ![]() The clinical evidence for this authorisation is based on data from two clinical trials on approximately 3,100 individuals aged 18 to 84 years. It is given as two injections, four weeks part. The SKYCovion vaccine combines a part of the SARS-CoV-2 virus spike protein with an âadjuvantâ â an additional ingredient designed to trigger a stronger immune response. The authorisation follows advice received from the independent Commission on Human Medicines (CHM). ![]() It becomes the 8th COVID-19 vaccine authorised by the UKâs independent medicines regulator. If we have a ray or wave or nano proton size beam t
0 Comments
Leave a Reply. |